Terminated PHASE2 INTERVENTIONAL 2-arm NCT01769443

Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation

A Prospective, Randomized, Multicenter, Two-Parallel Arm Study Evaluating the Overall Efficacy and Safety of Desensitization Therapy on Selected Patients Awaiting Heart Transplantation

Sponsor: Clinical Trials in Organ Transplantation

Conditions Heart Transplant Heart Transplantation Primary Heart Transplant

Interventions bortezomib plasmapheresis

Updated 7 times since 2017 Last updated: Oct 14, 2015 Started: Jun 30, 2013 Primary completion: Jul 31, 2014 Completion: Jul 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Inability to enroll within funding period

Other terminated trials from Clinical Trials in Organ Transplantation

See all terminations from Clinical Trials in Organ Transplantation

A PHASE2 clinical study on Heart Transplant and Heart Transplantation, this trial is terminated or withdrawn. The trial is conducted by Clinical Trials in Organ Transplantation and has accumulated 7 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Trials in Organ Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)

Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beverly Hills, United States , Boston, United States , Chicago, United States , Cleveland, United States , Houston, United States , Minneapolis, United States , Murray, United States , New Haven, United States , New York, United States , Philadelphia, United States and 2 more locations